Context Therapeutics
Price & Volume
Stats
See moreOpen | $1.80 |
Previous Close | $1.81 |
Day Range | $1.78-$2.07 |
52W Range | $0.49-$2 |
Market Cap | $166.3M |
Shares Short | 418,668 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.24 |
News
See moreYahoo Finance • last month
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
Yahoo Finance • 3 months ago
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
Yahoo Finance • 3 months ago
Context Therapeutics GAAP EPS of -$0.10 misses by $0.01
Yahoo Finance • 3 months ago
Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
About
CEO | Mr. Martin A. Lehr |
CFO | Ms. Jennifer Minai-Azary |
Address | 2001 Market Street, Philadelphia, PA, United States, 19103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
